Integrated Analyses of m6A Regulator-Based Signature on Its Clinical Application and Immunogenomic Landscape in Stomach Adenocarcinoma.

Lan ZhangQing ZhangZebo HuangMingxia ZhuTongshan WangWei Zhu Xiaping Wang Xin Zhou

Published in: BioMed research international (2022)

Our m6ASig scoring system could characterize TME immune cell infiltration, thus predict patient's prognosis and immunotherapy and chemotherapy efficacy, offering a novel tool for the individualized therapeutic implications for STAD patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
squamous cell carcinoma
locally advanced
prognostic factors
case report
radiation therapy